The_Cannabis_Investor_SPAC_Edition
 
 

Welcome to the second edition of The Cannabis Investor! 

Viridian Capital Advisors and IMN's IC3 event series have collaborated to bring you this exclusive series of cannabis investment newsletters, articles, podcasts and CEO interviews, providing tailored content to guide your investment strategy and drive your business forward in the legal cannabis space.
Viridian Capital Advisors was founded in 2014 in New York City as one of the first finance and advisory practices in the legal cannabis market and has advised and financed select cannabis companies in the U.S. and Israel. The firm also publishes the Viridian Cannabis Deal Tracker, the leading market intelligence service on cannabis investment, M&A and deal metrics.
In combination with IC3’s unparalleled industry network of stakeholders and investors via IMN’s extensive portfolio of investor events, the Cannabis Investor will provide insightful and actionable information for cannabis investors, operators and acquirers.
During this time of uncertainty and disruption to our daily lives, we understand it is even more important to stay connected and up-to-date with one of the fastest growing industries in the world, and our newsletter promises to provide an exclusive first-look at the data and market movements that will determine your investment strategies going forward, as well as continuing to facilitate connections with your peers.
 
 
 

In this SPAC-focused edition of The Cannabis Investor:

  • Scott Greiper talks with Bruce Linton, Chairman & CEO of Collective Growth Corp. about the process of forming a SPAC, raising capital, identifying acquisition targets and executing an IPO, while also giving his views on the future of the cannabis industry generally.
  • An exclusive, in-depth report on SPAC activity in the cannabis and hemp industries.
  • Information regarding next week’s SPAC webcast with three veteran investors.
 
 
Viridian_Podcast_II
 
 
SPAC_Podcast
 
 
 
 
PODCAST: Scott Greiper interviews cannabis industry veteran Bruce Linton, the Chairman & CEO of Collective Growth Corp, to discuss his Special Purpose Acquisition Corp. (SPAC) that has recently IPO’d on the Nasdaq
 
They talk about raising capital, targeting companies for acquisition and the benefits for sponsors, investors and sellers, while Bruce also shares his thoughts on the future of the legal cannabis industry, generally. 
 
 
 
listentopodcast
 
 
 
Header_break
 
SPAC_Article
 
 
By Viridian Capital Advisors
A SPAC (aka “Special Purpose Acquisition Corp.”) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.  It is formed by sponsors with experience and reputations to allow them to identify and complete a business combination with one or more target businesses that will ultimately be a successful public company.  Sponsors and management ideally are firms and/or individuals with demonstrated success in identifying, acquiring and operating growth businesses and with experience in the public company setting.
 
Between March 2019 and May 2020, eleven cannabis and hemp focused SPAC IPOs raised more than $2.6 billion.  This is more than all of the cannabis/hemp IPO activity in 2018 and 2019 combined.

Cannabis/Hemp SPAC IPOs Listed on U.S. and Canadian Exchanges
 
SPAC_chart_Viridian_new
 
 

What is a SPAC?

A SPAC (aka “Special Purpose Acquisition Corp.”) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.  It is formed by sponsors with experience and reputations to allow them to identify and complete a business combination with one or more target businesses that will ultimately be a successful public company.  Sponsors and management ideally are firms and/or individuals with demonstrated success in identifying, acquiring and operating growth businesses and with experience in the public company setting. 

SPACs first began to appear in the early 1990s as the next iteration of “blind pools” that became popular in the oil and gas sector in the 1980s. 

The SPAC structure offers opportunities for investors, management and target company sellers:

 
 
 
  • Investors: Allows investors to invest in a publicly traded acquisition platform backed by management teams that ideally have a track record of successful “roll-up” transactions.  Provides liquidity in the form of the public stock.
  • Management: Provides an acquisition platform that enables management teams to be aggressive buyers due to the cash on hand from the IPO and the ability to use their public traded stock as current for an acquisition.   
  • Target Company Sellers: Sellers know that a SPAC buyer is a well-funded buyer and that any stock portion of consideration paid for their business has the potential for current liquidity.
There are also several clear challenges to the publicly traded SPAC platform as an acquirer:  
  • Time Restrictions: Exchanges often require that an acquisition be completed within 24 months from the IPO, or shareholder capital must be returned.  A SPAC may seek a time extension of up to 36 months.
  • Acquisition Size Requirements: The initial acquisition target must have an aggregate fair market value of at least 80% of the value of IPO proceeds.  This can have the effect of narrowing the universe of target companies. 
  • Target Company Restrictions: Until closing of the IPO, a SPAC is not allowed to have substantive discussions with an acquisition target.
 
 
 
What Does this Mean for the Cannabis and Hemp Sectors? 
The amount of capital invested in cannabis and hemp SPAC IPOs in the last year, despite a broad decline in the industry’s capital markets, has significant and interesting implications:
  • Increased Industry M&A Activity: M&A activity in the cannabis and hemp markets came to a virtual halt in the last four quarters.  According to the Viridian Cannabis Deal Tracker, the number of M&A transaction fell by more than 65% over this period.  This decline was primarily due to the weakened state of public companies (that have been the most aggressive acquirers in the cannabis industry) due to shrinking stock prices and capital availability.  With the more than $2.5 billion raised by SPACs, there is more buying power in the market to drive M&A activity.
  • M&A Activity Diversifies from Plant Touching to Ancillary Companies: Over the past three years, licensed cultivation and retail companies have represented more than one-third of all target acquisitions, according to the Viridian Cannabis Deal TrackerThis was primarily driven by the Multi-State Operator (“MSO”), which was building a portfolio of state licensed operations in different states. However, the cannabis SPACs that listed on the NYSE or NASDAQ cannot buy federal illegal businesses in the U.S., even if they are legal at the state level. As such, we’re likely to see acquisitions of non-licensed ancillary cannabis businesses and U.S. hemp businesses that are federally legal.
  • Increased Investment Interest in Distressed/Undervalued Cannabis/Hemp Businesses: The SPAC IPO investor is not investing in an operating business, but rather an acquisition platform.  The fact that significant capital was drawn to the cannabis/hemp SPACs despite a protracted downturn in cannabis company stock prices and valuations, means that investors saw an opportunity to invest in distressed assets, or at the very least, attractive companies with reduced valuations.
  • Increased Institutional Investor Interest in the Cannabis and Hemp Sectors: The fact that the average industry SPAC over the past year raised more than $200 million in IPO proceeds, means that a significant portion of that demand came from institutional investors and large family offices.  This is a positive sign for the industry as these types of investors have been largely on the sideline of investing in the cannabis and hemp sectors.
  • Private Companies Will Benefit: As public companies, SPACs primarily target acquisitions of private companies. With the narrowing of capital availability in the industry over the past year, this should provide much needed liquidity potential for private companies. 
 
 
 
Conclusion

The rapid rise of the publicly traded SPAC in the cannabis/hemp industry portends well for investors, SPAC managers and target company acquisitions, particularly larger private companies.  We’re likely to see an increased pace of acquisition activity in the industry as the SPAC buyer has to move to comply with the time requirements for successfully completing its initial acquisition.

 
 
 
 
 
 
Header_break